Time-dependent changes in hypoxia- and gliosis-related factors in experimental diabetic retinopathy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time-dependent changes in hypoxia- and gliosis-related factors in experimental diabetic retinopathy
Authors
Keywords
-
Journal
EYE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-06
DOI
10.1038/s41433-018-0268-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Müller cells via Forkhead box protein O4
- (2018) Jiayu Zhang et al. Diabetes & Vascular Disease Research
- Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity
- (2017) Deborah K. VanderVeen et al. OPHTHALMOLOGY
- Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications
- (2016) Elizabeth P. Moran et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy
- (2016) Francesco Bandello et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreous ranibizumab for proliferative diabetic retinopathy
- (2016) Jonathan M. Gibson et al. Nature Reviews Endocrinology
- Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke
- (2016) Ziyan Zhang et al. NEUROBIOLOGY OF DISEASE
- Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment
- (2016) Eric L. Ross et al. JAMA Ophthalmology
- Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
- (2015) Ting-Ting Wan et al. BIOMEDICINE & PHARMACOTHERAPY
- Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial
- (2015) Jo�o Figueira et al. OPHTHALMOLOGICA
- Neuronal Cell Death in the Inner Retina and the Influence of Vascular Endothelial Growth Factor Inhibition in a Diabetic Rat Model
- (2014) Hae-Young Lopilly Park et al. AMERICAN JOURNAL OF PATHOLOGY
- α-Melanocyte-Stimulating Hormone Protects Retinal Vascular Endothelial Cells from Oxidative Stress and Apoptosis in a Rat Model of Diabetes
- (2014) Lijuan Zhang et al. PLoS One
- Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy
- (2013) Sirpa Loukovaara et al. ACTA OPHTHALMOLOGICA
- The Possible Mechanisms Underlying the Impairment of HIF-1α Pathway Signaling in Hyperglycemia and the Beneficial Effects of Certain Therapies
- (2013) Haijuan Xiao et al. International Journal of Medical Sciences
- Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
- (2013) Rafael Simó et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Crosstalk in the Retinal Neurovascular Unit – Lessons for the Diabetic Retina
- (2012) Y. Feng et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells
- (2011) Jingqi Yan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intravitreous Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor 1a in Patients With Proliferative Diabetic Retinopathy
- (2009) Xiaoqin Wang et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Time-dependent reduction of glutamine synthetase in retina of diabetic rats
- (2009) Yu Xu-hui et al. EXPERIMENTAL EYE RESEARCH
- Expression of Erythropoietin and Its Receptor in the Human Retina: A comparative study of diabetic and nondiabetic subjects
- (2008) M. Garcia-Ramirez et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started